$228.74
$0.00 (0.00%)
End-of-day quote: 12/15/2023
NasdaqGS:SGEN

Seattle Genetics Inc Annual Report

Year Year 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$1.96B $1.57B $2.18B $916.71M $654.70M $482.25M $418.15M $336.80M $286.76M $269.26M $210.81M $94.78M $107.47M $51.97M $35.24M $22.42M $10.01M $9.76M $6.70M
GM % Gross Margin %
10.60% 2.17% 51.97% 16.73% 0.17% -5.92% -0.83% 1.43% 9.40% 10.95% 12.83% -75.69% -36.23% -129.27% -214.86% 100.00% 0.00% -255.47% 0.00%
OM Operating Margin
-31.24% -43.32% 27.43% -24.06% -38.41% -40.60% -34.13% -35.91% -26.98% -23.35% -27.16% -152.35% -63.46% -163.30% -260.49% -248.19% 0.00% 0.00% 0.00%
EPS Earnings Per Share
$0.00 $-3.30 $-3.70 $3.26 $-1.33 $-1.41 $-0.88 $-1.00 $-0.93 $-0.62 $-0.51 $-0.46 $-1.34 $-0.66 $-0.90 $-1.09 $-0.80 $-0.74 $-0.70 $-1.80
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
-0.00% -0.00% 0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% 0 -0.00% 0 0
Sha. Shares
186.56m 183.38m 180.9m 171.99m 160.26m 144.4m 142.19m 139.67m 123.97m 122.62m 119.71m 116.02m 101.61m 100.55m 79.79m 67.52m 51.03m 42.38m 41.98m
OCF Operating Cash Flow
$-453.75M $-499.01M $856.57M $-163.74M $-203.54M $-118.90M $-96.97M $-133.20M $-60.00M $-1.11M $10.88M $-124.03M $6.81M $-61.76M $-62.63M $39.83M $-35.18M $-25.47M $-23.28M
FCF Free Cash Flow
$-531.09M $-551.34M $774.16M $-234.49M $-224.76M $-147.62M $-124.81M $-146.60M $-77.18M $-23.26M $1.00M $-135.28M $-66.25M $-66.35M $-67.51M $35.55M $-36.86M $-26.87M $-29.00M
FCFS Free Cash Flow Per Share
$-2.88 $-3.03 $4.43 $-1.42 $-1.43 $-1.03 $-0.89 $-1.13 $-0.63 $-0.19 $0.00 $-1.20 $0.03 $-0.73 $-0.86 $0.58 $-0.76 $-0.64 $-0.73